Navigation Links
Reportlinker Adds Point of Care Diagnostics
Date:12/2/2009

NEW YORK, Dec. 2 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Point of Care Diagnostics

http://www.reportlinker.com/p0166822/Point-of-Care-Diagnostics.html

Provides a complete review and analysis of the point of care (POC) diagnostics industry

Includes market forecasts through 2014 for the U.S. POC diagnostics industry

Covers federal regulation of POC testing

Analyzes market influences and predicts the future of POC

Reviews business activities of market leaders

Highlights emerging and leading technologies

Offers a thorough patent analysis.

Chapter- 1: INTRODUCTION -- Complimentary

STUDY GOALS AND OBJECTIVES 1

REASONS FOR DOING THE STUDY 1

SCOPE OF REPORT 1

DEFINING POC 2

METHODOLOGY 2

ANALYST CREDENTIALS 3

RELATED REPORTS 3

BCC ONLINE SERVICES 3

DISCLAIMER 4

Chapter-2: SUMMARY

OVERVIEW 5

MAJOR FINDINGS 5

SUMMARY TABLE FORECAST OF THE GLOBAL POC MARKET BY TEST TYPE, THROUGH 2014 ($ MILLIONS) 6

SUMMARY FIGURE FORECAST OF THE GLOBAL POC MARKET BY TEST TYPE, 2009 AND 2014 ($ MILLIONS) 7

Chapter-3: INDUSTRY OVERVIEW

WHAT IS POC TESTING? 8

OVERVIEW OF POC MARKET 8

POC AS PART OF CLINICAL DIAGNOSTICS INDUSTRY STRUCTURE 9

MEDICAL BENEFITS DERIVED FROM IMMEDIATE DIAGNOSTIC TESTING 9

POC TESTING SITES 10

TABLE 1 SELECTED KEY STATISTICS FOR POC TESTING SITES 10

HOME USE/SELF-CARE 11

EMERGENCY ROOMS (ER) 11

CRITICAL-CARE UNITS (CCU) 11

BEDSIDE TESTING 12

TABLE 2 NUMBER OF HOSPITALS FOR SELECTED COUNTRIES, 2009 12

OPERATING ROOMS (OR)/PROCEDURE ROOMS (PR) 12

PHYSICIANS OFFICES/ CLINICS/ TREATMENT CENTERS/OTHER NONCRITICAL=CARE SITES 13

TABLE 3 NUMBER OF U.S. HEALTHCARE FACILITIES BY TYPE, 2006* 13

POC PRODUCT SEGMENTS 13

POC CLINICAL ASSAY CATEGORIES 14

Blood Chemistry and Electrolytes 14

Cardiac Marker 14

Cholesterol Testing/Monitoring 14

Drug and Alcohol Screening 15

Glucose Testing and Monitoring 15

Infectious Disease Testing 15

Pregnancy and Fertility Testing 15

Hemoglobin and Hemostasis 16

Tumor Marker 16

Urinalysis/Urine Chemistry 17

COMMONLY PERFORMED POC TESTS 17

TABLE 4 SELECTED POC TESTS - CLIA WAIVED 17

TABLE 4 (CONTINUED) 18

SIGNIFICANCE OF CLIA IN THE UNITED STATES 18

SIGNIFICANCE OF CLIA IN THE UNITED STATES (CONTINUED) 19

OTHER REGULATORY AGENCIES 20

Good Manufacturing Practice (GMP) 20

TABLE 5 PERTINENT PARAMETERS OF GMP REGULATIONS AFFECTING IN VITRO DIAGNOSTICS 21

DRIVING FORCES OF THE POC MARKET 21

COST CONTAINMENT 22

Rising Healthcare Costs 22

TABLE 6 HEALTH EXPENDITURES AS PERCENT OF GDP BY COUNTRY, 1980-2006 (%) 22

FIGURE 1 HEALTH EXPENDITURES AS PERCENT OF GDP BY COUNTRY, 1980-2006 (%) 23

Average Length of Stay 23

TABLE 7 HOSPITAL USAGE STATISTICS, BY COUNTRY (DAYS) 24

FIGURE 2 HOSPITAL USAGE STATISTICS, BY COUNTRY (DAYS) 24

GLOBAL SHORTAGE OF HEALTHCARE WORKERS 25

TECHNOLOGICAL ADVANCEMENT 25

Availability - Ease of Use Devices 26

New Technologies 26

Biosensors 26

CHANGES IN INCIDENCE OF DISEASE 26

TABLE 8 PREVALENCE OF SELECTED DISEASES IN THE GLOBAL POPULATION, 2008-2009 (MILLION CASES) 27

Asthma 27

Cardiovascular Disease 28

Cancer 28

Diabetes 28

Diarrheal Disease 29

Infertility 29

Influenza 29

Malaria 29

Pregnancy 30

Pulmonary Disease 30

Tuberculosis 30

Aging Population 30

TABLE 9 ESTIMATED WORLD POPULATION AND ANNUAL GROWTH BY SELECTED AGE GROUP AND SELECTED YEARS, THROUGH 2030 (MILLIONS) 31

FIGURE 3 ESTIMATED WORLD POPULATION BY SELECTED AGE GROUP AND SELECTED YEARS, 2000-2030 (MILLIONS) 31

TABLE 10 WORLD POPULATION BY SELECTED COUNTRY, THROUGH 2014 (MILLIONS) 32

FIGURE 4 WORLD POPULATION BY SELECTED COUNTRY, 2007-2014 (MILLIONS) 33

Chapter-4: THE POC MARKET

MARKET OVERVIEW 34

TABLE 11 GLOBAL FORECAST FOR THE POC MARKET BY SEGMENT, THROUGH 2014 ($ MILLIONS) 34

FIGURE 5 GLOBAL FORECAST FOR THE POC MARKET BY SEGMENT, 2007-2014 ($ MILLIONS) 35

COMPETITOR MARKET SHARE 35

COMPETITOR MARKET SHARE (CONTINUED) 36

TABLE 12 MARKET SHARE OF POC MARKET PARTICIPANTS, 2009 (PERCENT/$ MILLIONS) 37

MARKET SHARE OF POC MARKET PARTICIPANTS, 2009 (%) 38

MARKET STRUCTURE 38

DISTRIBUTION 38

FIGURE 7 DISTRIBUTION CHANNELS: POC DIAGNOSTIC DEVICES 39

PROMOTION 39

STRATEGIC ALLIANCES AND MERGERS 39

MARKET COMPONENTS 40

BLOOD CHEMISTRY AND ELECTROLYTE TESTING 41

Blood Chemistry Parameters 41

Electrolytes 41

CLIA Quality Control (QC) Requirements for Blood Gas Analysis 41

Market Size 42

TABLE 13 FORECAST OF THE GLOBAL POC BLOOD GAS/ELECTROLYTE TESTING MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 43

FIGURE 8 FORECAST OF THE GLOBAL POC BLOOD GAS/ELECTROLYTE TESTING MARKET BY REGION, 2007-2014 ($ MILLIONS) 43

Market Participants and Market Shares 43

TABLE 14 RELATIVE MARKET SHARE OF POC BLOOD CHEMISTRY ANALYZER MANUFACTURERS BY COMPANY, 2009 (PERCENT/$ MILLIONS) 44

FIGURE 9 RELATIVE MARKET SHARE BLOOD GAS ANALYZER MANUFACTURERS BY COMPANY, 2009 (%) 45

TABLE 15 RECENTLY (2008-2009) CLIA-APPROVED BLOOD CHEMISTRY ANALYZERS 45

Radiometer America, Inc. 46

-- ABL80 FLEX 46

-- NPT7 46

-- RADIANCE STAT Analyzer and Data Management Software 47

Nova Biomedical 47

-- Stat Profile pHOx Product Line 47

TABLE 16 NOVA BIOCHEMICAL POC STAT PROFILE PHOX SERIES BY AVAILABLE TESTS 48

-- Stat Profile CCX Product Line 49

TABLE 17 NOVA BIOCHEMICAL POC STAT PROFILE CCX SERIES BY AVAILABLE TESTS 49

-- Point-of-Care Manager (PDM) 50

-- Cumulative Patient Reports 50

Siemens Healthcare 51

-- RAPIDPoint 400/405 51

-- RAPIDComm Data Management System 51

Roche Diagnostics 52

-- Cobas b 121 System 52

-- Cobas b 221 Blood Gas System 52

Abbott Diagnostics 52

-- i-STAT 52

International Technidyne Corp. (ITC) 53

-- IRMA TRUpoint Blood Analysis System 53

-- AVOXimeter Whole Blood Co-Oximeter/Oximeter System 53

CARDIAC MARKER TESTING 53

Market Size 53

TABLE 18 FORECAST OF THE GLOBAL POC CARDIAC MARKER TESTING MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 54

FIGURE 10 FORECAST OF THE GLOBAL POC CARDIAC MARKER TESTING MARKET BY REGION, 2007-2014 ($ MILLIONS) 54

Market Participants and Market Shares 55

TABLE 19 RELATIVE MARKET SHARE OF POC CARDIAC MARKER MANUFACTURERS BY COMPANY, 2009 (PERCENT/$ MILLIONS) 55

FIGURE 11 RELATIVE MARKET SHARE OF POC CARDIAC MARKER MANUFACTURERS BY COMPANY, 2009 (%) 55

Inverness Medical Innovations 56

-- Triage System 56

Roche 57

-- Cardiac Reader System 57

Abbott 57

-- iSTAT 1 57

Response Biomedical 58

-- RAMP System 58

CHOLESTEROL TESTING 58

Market Size 59

TABLE 20 FORECAST OF THE GLOBAL CHOLESTEROL POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 59

FIGURE 12 FORECAST OF THE GLOBAL CHOLESTEROL POC RAPID TEST MARKET, 2007-2014 ($ MILLIONS) 60

Market Participants and Market Shares 60

TABLE 21 RELATIVE MARKET SHARE OF CHOLESTEROL POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS) 61

FIGURE 13 RELATIVE MARKET SHARE OF CHOLESTEROL POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%) 61

TABLE 22 RECENTLY (2008-2009) CLIA-APPROVED CHOLESTEROL TESTS 62

Inverness Medical Innovations 62

Roche Diagnostics 62

Abaxis 62

DRUG AND ALCOHOL ABUSE TESTING 63

Market Size 63

TABLE 23 FORECAST OF THE GLOBAL DRUG AND ALCOHOL POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 64

FIGURE 14 FORECAST OF THE GLOBAL DRUG AND ALCOHOL POC RAPID TEST MARKET BY REGION, 2007-2014 ($ MILLIONS) 64

Market Participants and Market Shares 64

TABLE 24 RELATIVE MARKET SHARE OF DRUG AND ALCOHOL POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (PERCENT/$ MILLIONS) 65

FIGURE 15 RELATIVE MARKET SHARE OF DRUG AND ALCOHOL POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%) 66

TABLE 25 RECENTLY (2008-2009) CLIA-APPROVED POC DRUG AND ALCOHOL SCREENING TESTS BY MANUFACTURER 66

TABLE 25 (CONTINUED) 67

Inverness Medical Innovations 67

Phamatech 68

Psychemedics 68

Orasure Technologies 68

GLUCOSE TESTING 69

Market Size 70

TABLE 26 FORECAST OF THE GLOBAL POC GLUCOSE METER MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 71

FIGURE 16 FORECAST OF THE GLOBAL POC GLUCOSE METER MARKET BY REGION, 2007-2014 ($ MILLIONS) 71

TABLE 27 MARKET SHARE FOR THE GLOBAL POC GLUCOSE METER MARKET BY COMPONENT, 2009 ($ MILLIONS) 72

FIGURE 17 MARKET SHARE FOR THE GLOBAL POC GLUCOSE METER MARKET BY COMPONENT, 2009 (%) 72

Market Participants and Market Shares 72

TABLE 28 RELATIVE MARKET SHARE FOR GLUCOSE METERS AND SUPPLIES MANUFACTURERS BY COMPANY, 2009 (PERCENT/$ MILLIONS) 73

FIGURE 18 RELATIVE MARKET SHARE FOR GLUCOSE METERS AND SUPPLIES MANUFACTURERS BY COMPANY, 2009 (%) 73

TABLE 29 RECENTLY (2008-2009) APPROVED CLIA-WAIVED BLOOD GLUCOSE METERS BY MANUFACTURER 74

TABLE 29 (CONTINUED) 75

TABLE 29 (CONTINUED) 76

TABLE 29 (CONTINUED) 77

Roche Diagnostics 77

-- Accu-Chek Active System 77

-- Accu-Chek Inform System 77

-- Accu-Chek Inform II 78

-- Accu-Chek Voicemate System 78

Johnson and Johnson 78

-- LifeScan - OneTouch Ultra Meter 79

-- LifeScan - OneTouch Ultra 2 Meter 79

-- LifeScan OneTouch UltraSmart Meter 79

-- LifeScan OneTouch InDuo System 80

-- LifeScan OneTouch Basic Meter 80

-- LifeScan OneTouch SureStep Meter 80

-- LifeScan OneTouch UltraLink Meter 81

-- LifeScan OneTouch Diabetes Management Software 81

Abbott Diabetes Care 81

-- FreeStyle Blood Glucose Monitoring System 82

-- Precision Xtra Blood Glucose and Ketone Monitoring System 82

-- i-STAT 1 83

Home Diagnostics, Inc. 83

-- Sidekick Testing System 83

-- TrueTrack Smart System 83

-- Prestige IQ Blood Glucose Monitor 84

TABLE 30 SELECTED LISTING OF RETAILERS SELLING HOME DIAGNOSTIC'S METERS 84

Data Management Systems 84

TABLE 31 SELECTED LISTING OF BLOOD GLUCOSE MONITORS CAPABLE OF INTERACTING WITH COMPUTER SOFTWARE BY COMPANY 85

INFECTIOUS DISEASE TESTING 85

Strep A 86

TABLE 32 RECENTLY (2008-2009) CLIA-APPROVED STREP A TESTS BY MANUFACTURER 86

Influenza 86

TABLE 33 RECENTLY (2008-2009) CLIA-APPROVED INFLUENZA TESTS BY MANUFACTURER 87

Chlamydia/Trichomonas 87

TABLE 34 RECENTLY (2008-2009) CLIA-APPROVED RSV TESTS BY MANUFACTURER 88

HIV Testing 88

Inverness Medical 88

OraSure 89

Trinity Biotech, plc 89

Infectious Mononucleosis 89

TABLE 35 RECENTLY (2008-2009) CLIA-APPROVED INFECTIOUS MONONUCLEOSIS TESTS 89

H. pylori 90

TABLE 36 RECENTLY (2008-2009) CLIA-APPROVED H. PYLORI TESTS BY MANUFACTURER 90

Market Size 90

TABLE 37 FORECAST OF THE GLOBAL INFECTIOUS DISEASE POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 91

FIGURE 19 FORECAST OF THE GLOBAL INFECTIOUS DISEASE POC RAPID TEST MARKET BY REGION, 2007-2014 ($ MILLIONS) 91

TABLE 38 MARKET SHARE FOR THE GLOBAL POC INFECTIOUS DISEASE MARKET BY TEST TYPE, 2009 ($ MILLIONS) 92

FIGURE 20 MARKET SHARE FOR THE GLOBAL POC INFECTIOUS DISEASE MARKET BY TEST TYPE, 2009 (%) 92

Market Participants and Market Shares 93

TABLE 39 RELATIVE MARKET SHARE OF INFECTOUS DISEASE POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS) 93

FIGURE 21 RELATIVE MARKET SHARE OF INFECTIOUS DISEASE POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%) 94

Strep A 94

Influenza 94

Chlamydia 95

PREGNANCY AND FERTILITY TESTING 95

Market Size 95

TABLE 40 FORECAST OF THE GLOBAL PREGNANCY/FERTILITY POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 96

FIGURE 22 FORECAST OF THE GLOBAL INFECTIOUS DISEASE POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 96

TABLE 41 MARKET SHARE FOR THE GLOBAL POC PREGNANCY/FERTILITY MARKET BY TEST TYPE, 2009 (PERCENT/$ MILLIONS) 97

FIGURE 23 MARKET SHARE FOR THE GLOBAL POC PREGNANCY/FERTILITY MARKET BY TEST TYPE, 2009 (%) 97

Market Participants and Market Shares 97

TABLE 42 RELATIVE MARKET SHARE OF PREGNANCY/FERTILITY POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS) 98

FIGURE 24 RELATIVE MARKET SHARE OF PREGNANCY/FERTILITY POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%) 98

TABLE 43 RECENT (2008-2009) CLIA APPROVED PREGNANCY TESTS BY MANUFACTURER 99

TABLE 43 (CONTINUED) 100

HEMOGLOBIN/HEMOSTASIS 100

Hematology and Hemostasis 100

Hemostasis (Coagulation) 101

Market Size 101

TABLE 44 FORECAST OF THE GLOBAL HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 102

FIGURE 25 FORECAST OF THE GLOBAL HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MARKET BY REGION, 2007-2014 ($ MILLIONS) 102

Market Participants and Market Shares 102

TABLE 45 RELATIVE MARKET SHARE OF HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS) 103

FIGURE 26 RELATIVE MARKET SHARE OF HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%) 103

TABLE 46 RECENTLY (2008-2009) CLIA APPROVED HEMATOLOGY TESTS 104

TUMOR MARKER TESTING 104

Fecal and Gastric Occult Blood 104

Bladder Tumor Antigen Test 104

Market Size 104

TABLE 47 FORECAST OF THE GLOBAL TUMOR MARKER POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 105

FIGURE 27 FORECAST OF THE GLOBAL TUMOR MARKER POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 105

Market Participants and Market Shares 106

TABLE 48 RELATIVE MARKET SHARE OF TUMOR MARKER POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS) 106

FIGURE 28 RELATIVE MARKET SHARE OF TUMOR MARKER POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%) 106

TABLE 49 RECENTLY (2008-2009) CLIA APPROVED FECAL OCCULT BLOOD TESTS BY MANUFACTURER 107

URINE CHEMISTRY TESTING 107

Market Size 107

TABLE 50 FORECAST OF THE GLOBAL POC URINE CHEMISTRY ANALYZER MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 108

FIGURE 29 FORECAST OF THE GLOBAL POC URINE CHEMISTRY ANALYZER MARKET, 2007-2014 ($ MILLIONS) 109

Market Participants and Market Shares 109

TABLE 51 RELATIVE MARKET SHARE OF POC URINE CHEMISTRY ANALYZER MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS) 110

FIGURE 30 RELATIVE MARKET SHARE OF POC URINE CHEMISTRY ANALYZER MANUFACTURERS BY COMPANY, 2009 (%) 110

TABLE 52 RECENTLY (2008-2009) CLIA-APPROVED URINE CHEMISTRY ANALYZERS BY MANUFACTURER 111

TABLE 52 (CONTINUED) 112

MISC TESTING 112

Vaginal pH Tests 113

TABLE 53 RECENTLY (2008-2009) CLIA-APPROVED VAGINAL PH TESTS BY MANUFACTURER 113

Thyroid Stimulating Hormone (TSH) Tests 113

TABLE 54 RECENTLY (2008-2009) CLIA-APPROVED TSH TESTS BY MANUFACTURER 113

Male Reproductive Tests 113

TABLE 55 RECENTLY (2008-2009) CLIA-APPROVED MALE REPRODUCTIVE TEST BY MANUFACTURER 113

Chapter-5: TECHNOLOGY APPLICATIONS

BIOSENSORS 114

WHAT ARE BIOSENSORS? 114

Catalytic Sensors 114

Affinity Sensors 115

ELECTRODES 115

WHAT ARE ELECTRODES? 115

What are Electrodes? (Continued) 116

Chapter-6: PATENT ANALYSIS

NUMBER OF RECENTLY ISSUED PATENTS 117

TABLE 56 RESULTS OF U.S. PATENT SEARCH FOR POC CATEGORIES, SEPTEMBER 2008--SEPTEMBER 2009 (NUMBER) 117

FIGURE 31 U.S. PATENTS BY POC CATEGORIES, SEPTEMBER 2008-SEPTEMBER 2009 (NUMBER) 118

ANALYSIS OF PATENT BY SUBJECT 118

TABLE 57 U.S. PATENTS BY SUBJECT AREA, SEPTEMBER 2008 TO SEPTEMBER 2009 (NUMBER) 118

PATENT ASSIGNEES 119

TABLE 58 U.S. PATENT ASSIGNEES, SEPTEMBER 2008 TO SEPTEMBER 2009 (NUMBER) 119

FIGURE 32 U.S. PATENTS BY COUNTRY, SEPTEMBER 2008-SEPTEMBER 2009 (NUMBER) 120

RECENTLY ISSUED PATENTS 120

GLUCOSE METERS 120

HEMATOLOGY 121

Hematology (Continued) 122

COAGULATION ASSAY 123

IMMUNOASSAY 123

HEMATOLOGY 124

Hematology (Continued) 125

Chapter-7: WORLDWIDE POC MARKET

MARKET SIZE 126

TABLE 59 GLOBAL FORECAST (U.S. AND WORLDWIDE) FOR THE POC MARKET, THROUGH 2014 126

TABLE 59 (CONTINUED) 127

FIGURE 33 GLOBAL (U.S. AND WORLDWIDE) FORECAST FOR THE POC MARKET 2009 AND 2014 ($ MILLIONS) 127

GLOBAL MARKET SHARES 128

TABLE 60 POC GLOBAL MARKET SHARE BY COUNTRY, 2009 (PERCENT/$ MILLIONS) 128

FIGURE 34 POC GLOBAL MARKET SHARE BY COUNTRY, 2009 (%) 129

PRESENCE OF MANUFACTURERS IN THE WORLDWIDE MARKET 129

TABLE 61 MARKET SHARE OF TOP 10 POC MARKET PARTICIPANTS, 2009 ($ MILLIONS) 130

FIGURE 35 MARKET SHARE OF TOP 10 POC MARKET PARTICIPANTS, 2009 (%) 131

Chapter-8: PROFILES OF MAJOR MARKET PARTICIPANTS

OVERVIEW OF MARKET PARTICIPANTS 132

COMPANY PROFILES 132

ABAXIS 132

TABLE 62 ABAXIS' COMPANY REVENUES, 2007-2010* ($ MILLIONS) 133

ABBOTT LABORATORIES 134

TABLE 63 ABBOTT'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 135

BECTON, DICKINSON, & CO. 135

TABLE 64 BD'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 136

DANAHER CORP./RADIOMETER 136

TABLE 65 DANAHER'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 137

INTERNATIONAL TECHNIDYNE CORP. 137

TABLE 66 THORATEC'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 138

INVERNESS MEDICAL INNOVATIONS 138

TABLE 67 INVERNESS MEDICAL'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 139

JOHNSON & JOHNSON 139

TABLE 68 JOHNSON & JOHNSON'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 140

NOVA BIOMEDICAL 140

ORASURE TECHNOLOGIES 140

OraSure Technologies (Continued) 141

TABLE 69 ORASURE'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 142

QUIDEL CORP. 142

TABLE 70 QUIDEL'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 143

ROCHE 143

TABLE 71 ROCHE GROUP'S REVENUES, 2006-2009 ($ MILLIONS) 144

SIEMENS MEDICAL SOLUTIONS 144

TABLE 72 SIEMENS' COMPANY REVENUES, 2006-2009 ($ MILLIONS) 145

Chapter-9: APPENDIX

APPENDIX 146

KEY SOURCES OF INFORMATION 146

ABAXIS 146

ABBOTT LABORATORIES 146

BECKMAN COULTER, INC. 146

CHURCH & DWIGHT CO., INC. 146

CLINICAL DIAGNOSTICS DIVISION 146

BECTON DICKINSON & CO. 147

HEMOCUE AB 147

HENRY SCHEIN, INC. 147

HOME DIAGNOSTICS, INC. 147

INTERNATIONAL TECHNIDYNE CORP. 147

INVERNESS MEDICAL INNOVATIONS 147

JOHNSON & JOHNSON 148

NOVA BIOMEDICAL 148

ORASURE TECHNOLOGIES 148

PHAMATECH, INC. 148

PSS WORLD MEDICAL, INC. 148

PSYCHEMEDICS CORP. 148

QUEST DIAGNOSTICS 149

QUIDEL CORP. 149

RADIOMETER AMERICA, INC. 149

RESPONSE BIOMEDICAL CORP. 149

ROCHE 149

SIEMENS MEDICAL SOLUTIONS 150

TRINITY BIOTECH, PLC 150

To order this report:

Diagnostics Industry: Point of Care Diagnostics

More Market Research Report


Contact:
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
2. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
3. Reportlinker Adds Markets for Advanced Wound Care Technologies Report
4. Reportlinker Adds Antiseptics and Disinfectants Report
5. Reportlinker Adds Commercial Amino Acids Report
6. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
7. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
8. Reportlinker Adds Pediatric Health Care Products and Services Report
9. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
10. Reportlinker Adds 2008/2009 Healthcare Research Review Report
11. Reportlinker Adds Therapeutics and Diagnostics for Womens Disorders Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Francisco, CA (PRWEB) , ... February 08, 2016 , ... ... raise $792,000 to help combat pancreatic cancer. , Gary D. Radine, who recently retired ... also was the American Cancer Society’s 2015 CEO of the Year , helped ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... of organizations. DocuSyst provides a cloud hosted environment for FileHold software that ... integration with various 3rd party applications using the FileHold web services API. DocuSyst ...
(Date:2/8/2016)... ... February 08, 2016 , ... TopConsumerReviews.com recently awarded their ... removal products. , Moles are derived from a cluster of melanin when exposed to ... wrong places and create a lifetime of embarrassment. Historically, mole removal has ...
(Date:2/8/2016)... ... February 08, 2016 , ... According to ... the U.S. require dental technicians to be certified or obtain continuing education. To ... created the “What’s In Your Mouth?” campaign to inform dentists and patients about ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... has added Kybella® to his medical and surgical expertise. Technically known as deoxycholic ... injectable medication used as a non-surgical alternative for reduction of fat below the ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... --  Intarcia Therapeutics, Inc. today announced the appointment ... newly created role of Vice President, Head of Global ... decades of leadership experience at leading pharmaceutical, biotechnology, and ... center. Most recently Dr. Yee served as VP, Head ... Medical Officer at AstraZeneca, where he led medical affairs ...
(Date:2/8/2016)... 8, 2016 /PRNewswire/--  Cell Applications, Inc. and ... services are now available in North ... (3D) bioprinting approach called the "Kenzan Method." Utilizing ... a state-of-the-art robotic system that fabricates 3D tissue ... pay-for-service bio-printing model that makes scaffold-free tissue available ...
(Date:2/8/2016)... -- Velano Vascular, a medical technology company transforming and ... practitioners, announced today that the company has raised an ... proceeds from this financing, an extension of a $5 ... support the development and commercialization of the company,s inpatient ... Philadelphia , and a number of ...
Breaking Medicine Technology: